Filing Details
- Accession Number:
- 0001181431-11-013962
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-01 16:29:55
- Reporting Period:
- 2011-02-28
- Filing Date:
- 2011-03-01
- Accepted Time:
- 2011-03-01 16:29:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1097955 | Md J Mitchell Blutt | 1300 North Kellogg Drive Suite D Anaheim CA 92807 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-28 | 110,000 | $12.83 | 674,952 | No | 4 | S | Indirect | See FN 1 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See FN 1 |
Footnotes
- The reported securities are directly owned by Consonance Capital Master Account, L.P. and may be deemed beneficially owned by Consonance Capital Advisors, L.P., of which Dr. Blutt is the managing member. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Billionaire Hedge Funds
